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Previewsabsence of HP1, the level of compaction
typical for heterochromatin cannot be
achieved, and the H3K9me3 mark will be
lost rapidly.
Heterochromatin has been linked to a
G1/S phase transition checkpoint in other
organisms. It is conceivable that a similar
checkpoint is in place in the blood-stage
malaria parasite, as it is crucial to closely
monitor the integrity of its heterochro-
matic domains to prevent revelation of
its entire antigenic repertoire simulta-
neously. The 50% replication defect in
the Hda2 knockdown probably reflects
the proportion of the parasite population
not fit for S phase entry due to insuffi-
cient heterochromatin integrity. In the
HP1 knockdown, which exhibits a com-
plete arrest in the cycle following HP1
depletion, none of the asexual parasites
fulfil the checkpoint criteria, exemplified
by the complete breakdown of var gene
silencing and the resulting hyperexpres-
sion of PfEMP1 on the surface of the
host cell.
Similar to the 50% replication defect
in the Hda2 knockdown, half of the HP1
knockdown population commits to game-150 Cell Host & Microbe 16, August 13, 2014tocytogenesis in the cycle of HP1 deple-
tion. This probably reflects the proportion
of the population expressing AP2-G to
levels sufficient to activate early gameto-
cyte genes.
These two papers report the induction
of gametocytogenesis by gene knock-
down. Until now, the only way of inducing
gametocytogenesis in vitro has been
applying environmental stress. The ques-
tion remains: what induces gametocyto-
genesis in vivo? Is there an external
signal? Is it merely stochastic? Also, it
remains to be explored experimentally
whether there is a direct link between
the frequency of var gene switching and
the rate of gametocyte conversion.
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Early in viral infection, the STAT1 transcription factor is rapidly transported into the nucleus using a noncon-
ventional import mechanism to establish an antiviral state. In this issue, Xu et al. (2014) show how the Ebola
virus VP24 protein precisely blocks specialized STAT1 import while leaving other cellular import processes
intact.As anyone stuck in traffic watching an
ambulance race past can appreciate, it
is important to make sure that emergency
responders have special access to road-
ways to ensure their rapid response. A
similar emergency response is mounted
in cells that sense viral infection via theinterferon (IFN) signaling cytokines, allow-
ing the host to rapidly establish an antiviral
state by upregulating the expression of
hundreds of genes, known collectively
as interferon-stimulated genes (ISGs).
Key to this signaling cascade is the phos-
phorylation and nuclear import of STAT1and STAT2 (signal transducer and acti-
vator of transcription) proteins, which
are powerful transcription activators that
switch on ISG expression. As part of the
rapid immune response, STAT1 nuclear
import is mediated in a noncanonical
way, akin to an ‘‘emergency access
A B C
Figure 1. Ebola VP24 Specifically Blocks the Noncanonical Nuclear Import of STAT1
(A) Most cellular proteins rely on a classical nuclear localization signal (cNLS) for their import into the nucleus, via cNLS binding to armadillo (ARM) repeats 2–8
(green) of karyopherin-a (KPNA) proteins, including the NPI-1 subfamily of KPNAs.
(B) Upon IFN binding to the IFN receptor on a cell surface, Janus kinases (JAK1 and TYK2) become activated and phosphorylate STAT1. Phosphorylated
STAT1 dimerizes and then presents a nonclassical NLS (ncNLS), which is recognized by ARMs 8–10 of NPI-1 KPNAs (blue) for nuclear import. STAT1 binding
to KPNAs does not interfere with cNLS binding, suggesting that both cargosmay be imported simultaneously. Once nuclear, dimeric STAT1 activates expression
of several hundred interferon stimulated genes (ISGs), which establish an antiviral state in the cell.
(C) Upon Ebola infection, STAT1 is phosphorylated normally but is unable to bind KPNA due to competition with Ebola VP24 for specific binding to ARMs 8–10.
This competitive mechanism of VP24 still allows cNLS-containing cargoes to bind KPNAs, thus specifically blocking only STAT1 import.
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Previewslane’’ to the nucleus. In this issue of Cell
Host & Microbe, Xu et al. (Xu et al., 2014)
use insights from structural biology and
biochemistry to uncover how Ebola virus
blocks this specialized access mecha-
nism to disable the innate immune system
with exquisite specificity.
The import of most proteins into the
nucleus depends on a combination
of karyopherin-a proteins (KPNA, also
known as importin-a) that directly bind
cargo proteins and karyopherin-b proteins
that carry the karyopherin-a-cargo com-
plex into the nucleus via the nuclear
pore. Typically, KPNA proteins recognize
and bind a classical nuclear localization
signal (cNLS) primarily composed of one
or two short regions of highly basic
residues on import cargoes (Figure 1A)
(Cook et al., 2007). STAT1, however, lacks
such a cNLS and instead relies on anoclassical NLS (ncNLS) for import
by only a subset of KPNAs, known as
NPI-1 karyopherins (KPNA1, KPNA5, and
KPNA6 or importin-a 5, 6 and 7). The
STAT1 ncNLS is exclusively presented
in the STAT1 dimer, allowing discrimina-
tion between the preactivation STAT1
monomer and the postactivation STAT1
dimer. Interestingly, cNLS cargos and
the STAT1 ncNLS bind physically distinct
armadillo (ARM) repeat regions of KPNAs
such that binding of STAT1 does not
compete with cNLS binding, suggesting
that both cargos can be carried at
the same time by the same KPNA (Reich
and Liu, 2006) (Figure 1B). Though this
specialized access to the nucleus by
STAT1 has been known for years, the
details of what comprises an ncNLS and
how NPI-1 KPNAs recognize such an
import signal have been elusive.Cell Host & Microbe 16Resolution of this conundrum has
now emerged from an unexpected
source: Ebola virus. Ebola virus and the
related Marburg virus are members of
the filoviridae, enveloped negative-sense
RNA viruses that can cause viral hemor-
rhagic fevers that can reach fatality rates
near 90%. One characteristic of Ebola
virus infections is the lack of IFN response
in infected cells, essentially nullifying
the innate immune response to viral infec-
tion. Such dysregulation of the innate
immune system is likely responsible for
the unchecked replication of the virus
and rapid dissemination throughout the
body (Basler and Amarasinghe, 2009).
Previous work by the Basler group and
colleagues showed that the VP24 protein
from Ebola, aminormatrix protein present
in incoming viral particles, was single-
handedly able to disrupt signaling by, August 13, 2014 ª2014 Elsevier Inc. 151
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PreviewsIFN-a/IFN-b and IFN-g by preventing
phosphorylated STAT1 from entering the
nucleus (Reid et al., 2006). Additional
biochemical mapping using truncations
and individual mutations revealed that
VP24 required the same regions on
KPNA1, KPNA5, and KPNA6 to bind to
these karyopherins as phosphorylated
STAT1 required for binding, suggesting
that VP24, like STAT1, contains a ncNLS
(Reid et al., 2007).
In the current study, Xu et al. (Xu et al.,
2014) reveal mechanistic details of
Ebola virus inhibition of STAT signaling
while simultaneously providing molecular
insight into STAT1 nuclear import. By
solving the crystal structure of VP24
bound to KPNA5, the authors showed
that VP24 tightly binds KPNA5 using an
extended surface to interact with the
three C-terminal ARMs of KPNA5. Using
these structural data, the authors showed
that the same residues required for
KPNA50s interaction with VP24 were
also required for interaction with STAT1,
thus providing the first structural and
biochemical glimpse of how KPNA can
recognize an ncNLS. These data also
elegantly explain the specificity of VP24
and STAT1 binding by only a subset of
KPNAs, as many of the critical binding
residues in KPNA5 are well conserved
among NPI-1 KPNAs, but not well
conserved among non-STAT1-binding
KPNAs. Expanding from KPNA5 binding
of an ncNLS to the in vivo function of
VP24, the authors showed that residues
in VP24 that make direct contacts to
KPNA5 are required to block nuclear
import of STAT1 and its transcriptional
functions. Thus, consistent with a previ-
ously proposed model (Reid et al., 2007),
VP24 binding to KPNA5 serves as a
competitive inhibitor of phosphorylated-
STAT1 binding. Importantly, although
VP24 directly interfered with nuclear
import of STAT1 via its ncNLS, it did not
block binding of a cNLS-containing
cargo protein by KPNA5. Thus, Ebola
virus does not inhibit all nuclear import
via NPI-1 KPNA proteins; this would
presumably be highly deleterious for the
virus. Instead, Ebola VP24 protein specif-152 Cell Host & Microbe 16, August 13, 2014ically blocks STAT1’s ‘‘emergency access
lane’’ to the nucleus with surgical preci-
sion (Figure 1C).
Why would Ebola virus choose this
strategy to antagonize the host immune
system? The finding that Ebola virus dis-
rupts STAT1 function is not unexpected,
given that IFN signaling is such an impor-
tant axis of the innate immune system.
Indeed, numerous viruses antagonize
STAT signaling by mechanisms such as
STAT1 and STAT2 protein degradation
or dephosphorylation of activated STAT1
(Najjar and Fagard, 2010), and these
would appear to be at least as effective
a strategy. However, encoding a compet-
itive inhibitor of STAT1-KPNA interaction
might present some evolutionary advan-
tages to Ebola. This would especially be
true if the constraint to maintain STAT1-
KPNA interactions imposes greater diffi-
culty for hosts to evolve away from
antagonism via ‘‘mimicry’’ by Ebola virus
VP24 (Elde and Malik, 2009). In contrast,
changes in STAT proteins at viral protein
binding interfaces might be sufficient to
escape antagonism by other mecha-
nisms, and therefore easier to evolve in
principle (Daugherty and Malik, 2012).
Interestingly, Ebola virus may not be
unique in employing this strategy; mea-
sles virus and rotavirus may also block
STAT1 nuclear import, although it remains
unclear whether they also employ a
competitive inhibitor (Yarbrough et al.,
2014).
By establishing a clear mechanism for
Ebola VP24 blockage of IFN signaling in
infected cells and structurally defining
the interaction between KPNAs and
ncNLSs, this work continues the long
tradition of using viruses to molecularly
dissect cellular pathways that are often
highly pleiotropic, especially in the field
of nucleocytoplasmic transport (Yar-
brough et al., 2014). For instance, one of
the important implications of this work is
a deeper understanding of the evolution
and functions of the ‘‘emergency access
lane’’ for nuclear import. Although we do
not know whether an ncNLS-mediated
STAT1 import is a superior strategy
compared to import using a cNLS, suchª2014 Elsevier Inc.a specialized system may have evolved
so that STAT1 does not disrupt, or is not
disrupted by, the import of normal cellular
cargos upon a cellular emergency such
as IFN induction (Reich and Liu, 2006).
By using Ebola virus VP24 as a tool, and
specific mutations of the newly defined
ncNLS-binding residues on KPNAs,
future work will be able to dissect which
additional cargoes use this specialized
system for nuclear import and with what
consequences. One thing is for certain:
with the ‘‘emergency access lane’’ in full
service, it allows pathogens like Ebola
virus to specifically block it without paying
any of the pleiotropic costs of blocking
nuclear import in general. Regular traffic
can flow unimpeded!ACKNOWLEDGMENTS
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